61 results
8-K
EX-99.2
NBSE
NeuBase Therapeutics Inc
22 May 23
Regulation FD Disclosure
7:00am
featured in an oral presentation at the American Society of Gene & Cell Therapy (“ASGCT”) 2023 Annual Meeting
Company to present additional data
8-K
EX-99.1
NBSE
NeuBase Therapeutics Inc
11 May 23
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
4:20pm
Society of Gene & Cell Therapy (“ASGCT”) 26th Annual Meeting to take place on May 16-20, 2023
Company to present additional data showcasing gene editing
8-K
EX-99.1
q9i0u3iy5n3v29
11 Aug 22
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022
8:05am
8-K
EX-99.1
9s9p hemx
12 May 22
NeuBase Therapeutics Reports Business Update and Financial Results
5:01pm
8-K
EX-99.2
vrty9mpa2b 5id173
8 Jun 21
Regulation FD Disclosure
2:01pm
8-K
EX-99.1
k99ti9xgb1
12 May 21
NeuBase Therapeutics Appoints Gerald J. McDougall to Board of Directors
4:30pm
8-K
ymidf nel81y0zqj
12 May 21
NeuBase Therapeutics Appoints Gerald J. McDougall to Board of Directors
4:30pm
8-K
EX-2.1
4t32gniq pdwn6
3 Jan 19
Entry into a Material Definitive Agreement
5:29pm
425
EX-2.1
191 llytruk
3 Jan 19
Business combination disclosure
5:28pm